Logo image of TLSA

TIZIANA LIFE SCIENCES LTD (TLSA) Stock Overview

NASDAQ:TLSA - BMG889121031 - Common Stock

1.81 USD
-0.02 (-1.09%)
Last: 8/29/2025, 8:00:01 PM
1.7807 USD
-0.03 (-1.62%)
After Hours: 8/29/2025, 8:00:01 PM

TLSA Key Statistics, Chart & Performance

Key Statistics
52 Week High2.6
52 Week Low0.63
Market Cap201.74M
Shares111.46M
Float63.47M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.11
PEN/A
Fwd PEN/A
Earnings (Next)10-13 2025-10-13
IPO11-20 2018-11-20
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


TLSA short term performance overview.The bars show the price performance of TLSA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40

TLSA long term performance overview.The bars show the price performance of TLSA in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100

The current stock price of TLSA is 1.81 USD. In the past month the price decreased by -23.95%. In the past year, price increased by 81%.

TIZIANA LIFE SCIENCES LTD / TLSA Daily stock chart

TLSA Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.87 371.68B
AMGN AMGEN INC 13.19 154.89B
GILD GILEAD SCIENCES INC 14.6 140.17B
VRTX VERTEX PHARMACEUTICALS INC 23.08 100.25B
REGN REGENERON PHARMACEUTICALS 12.72 61.55B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 58.53B
ARGX ARGENX SE - ADR 76.83 43.59B
ONC BEONE MEDICINES LTD-ADR 6.16 36.38B
INSM INSMED INC N/A 28.77B
BNTX BIONTECH SE-ADR N/A 24.04B
NTRA NATERA INC N/A 23.09B
BIIB BIOGEN INC 8.26 19.38B

About TLSA

Company Profile

TLSA logo image Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. The Company’s clinical pipeline includes drug assets for secondary progressive multiple sclerosis, Alzheimer’s, and ALS. Its lead immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer’s and other CNS indications. Its Anti-IL-6R mAb (TZLS-501), a fully human mAb, binds to both membrane-bound and soluble forms of IL-6R, an inflammatory cytokine driving chronic inflammation associated with autoimmune and cancer, reducing circulating levels of the IL-6 cytokine. Its oncology product candidate, Milciclib, is a combination therapy for the treatment of refractory solid tumors (being cancers which are non-responsive or become resistant to treatment), especially non-small cell lung cancer (NSCLC).

Company Info

TIZIANA LIFE SCIENCES LTD

3rd Floor, 11-12 St. James's Square

London SW1Y 4LB GB

CEO: Kunwar Shailubhai

Employees: 9

TLSA Company Website

TLSA Investor Relations

Phone: 442074952379

TIZIANA LIFE SCIENCES LTD / TLSA FAQ

What is the stock price of TIZIANA LIFE SCIENCES LTD today?

The current stock price of TLSA is 1.81 USD. The price decreased by -1.09% in the last trading session.


What is the ticker symbol for TIZIANA LIFE SCIENCES LTD stock?

The exchange symbol of TIZIANA LIFE SCIENCES LTD is TLSA and it is listed on the Nasdaq exchange.


On which exchange is TLSA stock listed?

TLSA stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for TIZIANA LIFE SCIENCES LTD stock?

7 analysts have analysed TLSA and the average price target is 8.16 USD. This implies a price increase of 350.83% is expected in the next year compared to the current price of 1.81. Check the TIZIANA LIFE SCIENCES LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is TIZIANA LIFE SCIENCES LTD worth?

TIZIANA LIFE SCIENCES LTD (TLSA) has a market capitalization of 201.74M USD. This makes TLSA a Micro Cap stock.


How many employees does TIZIANA LIFE SCIENCES LTD have?

TIZIANA LIFE SCIENCES LTD (TLSA) currently has 9 employees.


What are the support and resistance levels for TIZIANA LIFE SCIENCES LTD (TLSA) stock?

TIZIANA LIFE SCIENCES LTD (TLSA) has a support level at 1.74 and a resistance level at 1.83. Check the full technical report for a detailed analysis of TLSA support and resistance levels.


Should I buy TIZIANA LIFE SCIENCES LTD (TLSA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does TIZIANA LIFE SCIENCES LTD (TLSA) stock pay dividends?

TLSA does not pay a dividend.


When does TIZIANA LIFE SCIENCES LTD (TLSA) report earnings?

TIZIANA LIFE SCIENCES LTD (TLSA) will report earnings on 2025-10-13.


What is the Price/Earnings (PE) ratio of TIZIANA LIFE SCIENCES LTD (TLSA)?

TIZIANA LIFE SCIENCES LTD (TLSA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.11).


What is the Short Interest ratio of TIZIANA LIFE SCIENCES LTD (TLSA) stock?

The outstanding short interest for TIZIANA LIFE SCIENCES LTD (TLSA) is 0.92% of its float. Check the ownership tab for more information on the TLSA short interest.


TLSA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to TLSA. When comparing the yearly performance of all stocks, TLSA is one of the better performing stocks in the market, outperforming 93.18% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

TLSA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TLSA. The financial health of TLSA is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TLSA Financial Highlights

Over the last trailing twelve months TLSA reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS increased by 36.02% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -105.13%
ROE -301.4%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%26.02%
Sales Q2Q%N/A
EPS 1Y (TTM)36.02%
Revenue 1Y (TTM)N/A

TLSA Forecast & Estimates

7 analysts have analysed TLSA and the average price target is 8.16 USD. This implies a price increase of 350.83% is expected in the next year compared to the current price of 1.81.


Analysts
Analysts82.86
Price Target8.16 (350.83%)
EPS Next Y13.33%
Revenue Next YearN/A

TLSA Ownership

Ownership
Inst Owners2.73%
Ins Owners43.06%
Short Float %0.92%
Short Ratio1.6